FAME study can continue without change
pSivida Limited has announced that the FAME™ (Fluocinolone Acetonide in Diabetic Macular Edema) Study can continue under the current protocol. The trial is studying the use of Medidur FA in diabetic macular edema (DME). The FAME™ study is being conducted on 956 patients in the U.S., Canada, Europe and India and it consists of two, duplicate, double-masked, randomized and multi-center trials.

A new study shows that soft contact lens wear does not accelerate the development of nearsightedness in children. Findings from the largest randomized three-year study, which tracked the myopic progression of 484 children ages 8-11 randomly assigned to wear glasses or contact lenses, indicated that there was no clinically meaningful difference between the two forms of vision correction for the treatment of nearsightedness, a vision problem experienced by approximately one-third of the population. The new research further dispels a long held myth that soft contact lenses increase myopia progression more than other vision correction options.